RSU vesting adds shares to Tenet Healthcare (THC) CEO holdings

Rhea-AI Filing Summary

Tenet Healthcare CEO Saumya Sutaria reported an increase in directly owned shares through the vesting of restricted stock units. On February 24, 2026, 18,242 "2025 Restricted Stock Units" were exercised or converted, consistent with their one-for-one conversion into common stock.

The transaction delivered 18,242 shares of common stock at a stated price of $0.00 per share, reflecting settlement of time-based awards rather than an open-market purchase. Following these events, Sutaria directly owned 36,486 restricted stock units and 638,923 shares of common stock, all held as direct ownership.

Footnotes explain that the RSUs were granted under the 2019 Stock Incentive Plan on February 24, 2025, vest in three equal annual installments, and are settled in common stock upon vesting. The reported transaction reflects the first one-third of that grant vesting on February 24, 2026.

Insider Trade Summary

18,242 shares exercised/converted

Mixed 2 txns

Insider Sutaria Saumya

Role CEO

Type	Security	Shares	Price	Value
Exercise	2025 Restricted Stock Units	18,242	$0.00	--
Exercise	Common Stock	18,242	$0.00	--

Holdings After Transaction: 2025 Restricted Stock Units — 36,486 shares (Direct); Common Stock — 638,923 shares (Direct)

Footnotes (1)

1. Restricted stock units convert into common stock on a one-for-one basis. The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2025, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment vested on February 24, 2026. Time-based restricted stock units are settled in shares of the Company's common stock upon vesting.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sutaria Saumya

(Last) (First) (Middle)

14201 DALLAS PARKWAY

(Street)

DALLAS TX 75254

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TENET HEALTHCARE CORP [ THC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO

3. Date of Earliest Transaction (Month/Day/Year)
02/24/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/24/2026		M		18,242	A	(1)	638,923	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
2025 Restricted Stock Units	(2)	02/24/2026		M			18,242	(2)	(2)	Common Stock(3)	18,242	$0	36,486	D

Explanation of Responses:

1. Restricted stock units convert into common stock on a one-for-one basis.

2. The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2025, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment vested on February 24, 2026.

3. Time-based restricted stock units are settled in shares of the Company's common stock upon vesting.

	Chad J. Wiener, as Attorney-in-fact for Saumya Sutaria	02/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Tenet Healthcare (THC) CEO report in this Form 4 filing?

Tenet Healthcare CEO Saumya Sutaria reported vesting and conversion of restricted stock units into common shares. The filing shows equity compensation settling in stock, not an open-market trade, and updates his directly owned restricted stock units and common share holdings.

How many Tenet Healthcare shares did the CEO receive from RSU vesting?

The CEO received 18,242 shares of Tenet Healthcare common stock from restricted stock units vesting. These units converted into common stock on a one-for-one basis as part of an equity award granted under the 2019 Stock Incentive Plan and settling upon vesting.

What is the structure of the 2025 restricted stock unit grant for Tenet’s CEO?

The 2025 restricted stock units were granted on February 24, 2025 and vest in three equal annual installments. The first one-third vested on February 24, 2026, with time-based units settled in Tenet Healthcare common stock upon vesting according to the grant’s terms.

What are Saumya Sutaria’s Tenet Healthcare holdings after this Form 4 transaction?

After the reported transactions, Saumya Sutaria directly holds 36,486 restricted stock units and 638,923 shares of Tenet Healthcare common stock. These figures reflect updated direct ownership following the February 24, 2026 vesting and conversion of a portion of the 2025 RSU grant.

Did the Tenet Healthcare CEO buy or sell THC stock on the market in this filing?

The filing shows no open-market buying or selling of Tenet Healthcare stock by the CEO. Instead, it reports an exercise or conversion of restricted stock units into common shares at a stated price of $0.00, reflecting settlement of equity compensation upon vesting.